Larvol Delta - Efficacy-Safety-and-Tolerability-of-Two-Administrations-of-COMP360-in-Participants-With-TRD

psilocybin (COMP360) - Compass Pathways

http://clinicaltrials.gov/ct2/show/NCT05711940

Dec 15, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next